Chengdu huasun technology group Inc. , LTD. (SHE:000790)
China · Delayed Price · Currency is CNY 4.190
+0.020 (0.48%)
Jul 31, 2025, 2:45 PM CST
SHE:000790 Revenue
Chengdu huasun technology group Inc. , LTD. had revenue of 126.91M CNY in the quarter ending March 31, 2025, a decrease of -29.21%. This brings the company's revenue in the last twelve months to 811.61M, down -15.66% year-over-year. In the year 2024, Chengdu huasun technology group Inc. , LTD. had annual revenue of 863.98M, down -13.89%.
Revenue (ttm)
811.61M
Revenue Growth
-15.66%
P/S Ratio
3.25
Revenue / Employee
884.11K
Employees
918
Market Cap
2.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 863.98M | -139.40M | -13.89% |
| Dec 31, 2023 | 1.00B | 130.27M | 14.92% |
| Jan 1, 2023 | 873.10M | -81.58M | -8.55% |
| Jan 1, 2022 | 954.69M | 195.38M | 25.73% |
| Dec 31, 2020 | 759.31M | 13.97M | 1.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 41.48B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |